- Home
- RSLS vs RELI Comparison
RSLS vs RELI Comparison
Compare RSLS & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- RELI
- Stock Information
- Founded
- RSLS 2002
- RELI 2013
- Country
- RSLS United States
- RELI United States
- Employees
- RSLS N/A
- RELI N/A
- Industry
- RSLS Medical/Dental Instruments
- RELI Specialty Insurers
- Sector
- RSLS Health Care
- RELI Finance
- Exchange
- RSLS Nasdaq
- RELI Nasdaq
- Market Cap
- RSLS 3.2M
- RELI 3.4M
- IPO Year
- RSLS 2007
- RELI N/A
- Fundamental
- Price
- RSLS $0.31
- RELI $1.02
- Analyst Decision
- RSLS Hold
- RELI
- Analyst Count
- RSLS 1
- RELI 0
- Target Price
- RSLS N/A
- RELI N/A
- AVG Volume (30 Days)
- RSLS 36.0M
- RELI 41.3K
- Earning Date
- RSLS 04-04-2025
- RELI 05-19-2025
- Dividend Yield
- RSLS N/A
- RELI N/A
- EPS Growth
- RSLS N/A
- RELI N/A
- EPS
- RSLS N/A
- RELI N/A
- Revenue
- RSLS $8,006,000.00
- RELI $14,054,361.00
- Revenue This Year
- RSLS $52.80
- RELI N/A
- Revenue Next Year
- RSLS N/A
- RELI N/A
- P/E Ratio
- RSLS N/A
- RELI N/A
- Revenue Growth
- RSLS N/A
- RELI 2.35
- 52 Week Low
- RSLS $0.30
- RELI $0.97
- 52 Week High
- RSLS $29.00
- RELI $18.53
- Technical
- Relative Strength Index (RSI)
- RSLS 40.15
- RELI 27.49
- Support Level
- RSLS $0.30
- RELI $1.00
- Resistance Level
- RSLS $0.70
- RELI $1.07
- Average True Range (ATR)
- RSLS 0.28
- RELI 0.07
- MACD
- RSLS 0.04
- RELI -0.00
- Stochastic Oscillator
- RSLS 0.36
- RELI 13.24
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing an acquisition strategy, initially and primarily focused on wholesale and retail insurance agencies. Its primary strategy is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.